This is a compilation of the recent regulatory updates for Brazil. Every week, we post an update of what's new, which you can view here.
- January 5: The Brazilian Health Regulatory Agency has extended the deadline for commentary on its Normative Instruction phased implementation deadlines. The new deadline is February 17, 2020.
- November 10: The Brazilian Health Regulatory Agency has approved a draft of regulations that lay out initial responsibilities for stakeholders in the country’s pharmaceutical supply chain. The document will soon be published for public commentary.
- April 7: The official pilot phase for serialization in Brazil will end in April 2019. At that time, the government will use learnings from the pilot program to create the final technical guidelines and will publish them in the next few months. The final implementation deadline of April 2022 will not shift, but the implementation timeline is now 24 months instead of 36 months and will begin in April 2020.
- February 24: ANVISA's extended pilot is planned to run in parallel with the eight month review and final regulation period. This timing means the 36 month implementation timeline would begin in April 2019 and end in April 2022 for all companies that have a requirement under the law and the products that are covered by the law.
- June 3: ANVISA reviewed timelines and the pilot will be extended until April 2019. Communication standards are being considered for both vertical government reporting and a potential use for horizontal peer to peer communications. A new version of communications guidelines has been published.
- April 8: Updated SNCM technical guidelines were circulated for law, which is currently in a pilot testing stage.
- March 11: ANVISA published the list of the pilot participants for the May through September pilot.
- January 14: Pilot execution and testing is now going to get underway in April/May when the central system is ready for integration and data management.